Brgl antibody

Ref. 3D-10R-10800

Produktinformation

• Name: Brgl antibody

Beschreibung

The Brgl antibody is a monoclonal antibody that targets chemokine receptors and inhibits their activity. It has been shown to effectively block the binding of chemokines to their receptors, preventing the activation of downstream signaling pathways. This antibody is also able to bind to alpha-fetoprotein (AFP), a protein that is often elevated in certain types of cancer. By targeting AFP, the Brgl antibody can potentially inhibit the growth and spread of cancer cells. Additionally, this antibody has been found to be a potent family kinase inhibitor, blocking the activity of various kinases involved in cell signaling and proliferation. The Brgl antibody can be used in research settings as well as in the development of immunogenic compositions and polymers for targeted drug delivery. Its high specificity and affinity make it a valuable tool in Life Sciences research.

• Marke: Biosynth